Hospital Guide: Foshan Fosun Chancheng Hospital

As Foshan's first JCI-accredited tertiary private hospital and a flagship of Fosun Health, we pioneer robotic surgery and integrated women & children's care with a 65-year legacy of excellence.

I. Hospital Overview & Vision

Foundation: Established in 1960, rebranded in 2021 under Fosun Health; 1,500+ beds across three campuses (main hospital plus Magnolia Building).

Accreditations: JCI (Joint Commission International) for quality and safety standards. A Guangdong Summit Plan demonstration hospital for high-quality development.

Positioning: A core hub in Fosun Health's Greater Bay Area medical alliance, advancing the "Three Links" policy (medications, talent, information) with Hong Kong and Macao.

II. Cutting-Edge Medical Technologies

Da Vinci Xi Surgical Robot (4th Gen): Offers 10x magnified 3D HD vision, 540° rotating wrists, tremor filtration, and sub-millimeter precision — ideal for complex urologic and oncologic surgeries.

First case: Partial nephrectomy for a 40-year-old renal tumor patient (April 2023), preserving kidney function with minimal ischemia time.

Tumor Treatment Suite: Foshan's first M6 CyberKnife (stereotactic radiosurgery). Varian linear accelerators plus PET-CT for precision radiation therapy. Future: orthopedic surgical robots under procurement.

Hong Kong/Macao Medication & Device Access: Early adopter of FARAPULSE Pulsed Field Ablation (PFA) for cardiac arrhythmia (Nov 2023), performing mainland China's first PFA procedures. Enables use of 3 advanced drugs and 2 devices unavailable in mainland public hospitals.

III. Flagship Departments & Expert Teams

Scale: 550 beds, 18 specialized units, and over 1 million annual outpatient capacity.

Key services: High-risk obstetrics with MDT management for complex cases (e.g., a successful IVF at age 52). Neonatology with a 98.9% survival rate for preterm infants, including the rescue of a 530g micro-premature baby. Gynecologic oncology in alliance with Prof. Wang Yifeng's team (Nanfang Hospital) plus the M6 CyberKnife for minimally invasive tumor therapy.

Tech integration: AI-assisted delivery systems and bedside smart tablets for patient services.

Da Vinci Surgeon Group: Led by Prof. Huang Jian (Chair, Chinese Urological Association), Prof. Pan Zhizhong (colorectal oncology), and other national experts.

Cross-border collaboration: Hong Kong physicians from Asia Medical Specialists/DoctorNow provide on-site consultations. Remote DBS programming and tele-rehabilitation partnerships with Hong Kong and Macao platforms.

IV. Guangzhou-Foshan as a Medical Destination

Policy advantages: 240-hour visa-free transit for international travelers. The "Hong Kong-Macao Medication Link" grants access to globally approved drugs and devices at Foshan Chancheng Hospital.

Recovery & leisure: Proximity to Lingnan culture sites (Liangyuan Garden, Ancestral Temple) and thermal springs (Xiqiao Mountain). Post-op TCM rehabilitation (acupuncture, herbal therapy) at partnered wellness centers.

Guangzhou-Foshan integration: A 30-minute metro ride from Guangzhou South Station (Metro Line 2 to Shiwan Station). Direct high-speed rail links to Hong Kong (1.5 hrs) and Shenzhen (40 mins).

V. International Patient Logistics

Location: No. 6, Hengbin Road, Shiwan, Foshan (adjacent to Metro Line 2 Shiwan Station).

Accessibility: From Guangzhou Baiyun Airport, take Metro Line 3 to Line 2 (70 mins) or a taxi (50 km, ¥150-200). From Hong Kong, take the West Kowloon HSR to Guangzhou South then Metro Line 2 (2 hrs total).

Enhanced infrastructure: 3 underground passages (opened Dec 2024) link the hospital, metro, parking, and shopping areas — walkable in 5 mins.

One-stop coordination: Multilingual case managers (English/Cantonese).

Cultural support: Halal/Kosher meal options and prayer room access. Collaboration with international insurers (AXA, Bupa).